United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
418.58
-7.63 (-1.79%)
At close: Oct 24, 2025, 4:00 PM EDT
426.00
+7.42 (1.77%)
After-hours: Oct 24, 2025, 7:56 PM EDT

United Therapeutics Stock Forecast

Stock Price Forecast

The 15 analysts that cover United Therapeutics stock have a consensus rating of "Buy" and an average price target of $466.73, which forecasts a 11.50% increase in the stock price over the next year. The lowest target is $302 and the highest is $600.

Price Target: $466.73 (+11.50%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$302$466.73$463$600
Change-27.85%+11.50%+10.61%+43.34%

Analyst Ratings

The average analyst rating for United Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMay '25Jun '25Jul '25Aug '25Sep '25Oct '25
Strong Buy666666
Buy233355
Hold444444
Sell000000
Strong Sell000000
Total121313131515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Hold
Maintains
$328$435
HoldMaintains$328$435+3.92%Oct 10, 2025
UBS
UBS
Strong Buy
Maintains
$560$580
Strong BuyMaintains$560$580+38.56%Sep 29, 2025
RBC Capital
RBC Capital
Buy
Initiates
$569
BuyInitiates$569+35.94%Sep 26, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$405$525
BuyMaintains$405$525+25.42%Sep 10, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$510$575
BuyMaintains$510$575+37.37%Sep 5, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
3.28B
from 2.88B
Increased by 13.82%
Revenue Next Year
3.46B
from 3.28B
Increased by 5.71%
EPS This Year
28.09
from 24.64
Increased by 13.99%
EPS Next Year
29.38
from 28.09
Increased by 4.61%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.48B1.69B1.94B2.33B2.88B3.28B3.46B
Revenue Growth
2.38%13.63%14.88%20.20%23.63%13.82%5.71%
EPS
11.5410.0615.0019.8124.6428.0929.38
EPS Growth
--12.83%49.11%32.07%24.38%13.99%4.61%
Forward PE
-----14.9014.25
No. Analysts
-----1818
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High3.4B3.7B
Avg3.3B3.5B
Low3.1B3.0B

Revenue Growth

Revenue Growth20252026202720282029
High
19.1%
13.2%
Avg
13.8%
5.7%
Low
7.0%
-7.1%

EPS Forecast

EPS20252026202720282029
High34.2033.33
Avg28.0929.38
Low24.7524.70

EPS Growth

EPS Growth20252026202720282029
High
38.8%
18.7%
Avg
14.0%
4.6%
Low
0.4%
-12.1%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.